SEC ownership of PALISADE BIO, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001357459.

Comparable stake leader

Janus Henderson Group Ltd.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

50/50

Latest evidence

08 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Janus Henderson Group Ltd.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
08 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001357459
Issuer location
Carlsbad, CA

Ownership snapshot

Top shareholders of PALISADE BIO, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
08 Jul 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Janus Henderson Group Ltd. Showing 1-8 of 50 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 10%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 10%
RA CAPITAL MANAGEMENT, L.P. 9.9%
PERCEPTIVE ADVISORS LLC 7.9%
Commodore Capital LP 7.2%
Octagon Capital Advisors LP 6.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
10%
$27,835,737
14,885,421 shares
$0 28 Nov 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
9.9%
$30,835,838
17,620,479 shares
+$3,278,888 31 Mar 2026
PERCEPTIVE ADVISORS LLC
13F 13D/G
Company
7.9%
from 13D/G
$15,624,261
8,928,149 shares
31 Mar 2026
Commodore Capital LP
13D/G 13F
Company
7.2%
$21,641,858
12,366,776 shares
+$4,683,194 31 Mar 2026
Octagon Capital Advisors LP
13D/G 13F
Company
6.4%
$18,370,364
9,567,898 shares
$0 31 Dec 2025
BlackRock, Inc.
13D/G 13F
Company
6%
$21,811,785
10,436,760 shares
$0 30 Jun 2026
FRANKLIN RESOURCES INC
13D/G 13F
Company
6%
$21,358,511
9,163,990 shares
$0 31 Dec 2025
Soleus Capital Master Fund, L.P.
13D/G
5.4%
$18,239,690
9,353,687 shares
$0 26 May 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$152,240.

Buys
$267,938
Insiders: 2
Sells
$420,178
Insiders: 2
Net
-$152,240
Shares: -69,563
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 135,000 Shares: 204,563
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 125,000 198,678 $250,182 $409,879 -$159,697
3-6 0 5,885 $0 $10,299 -$10,299
6-9 10,000 0 $17,756 $0 +$17,756
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-17 of 17 reporting-owner rows connected to PALISADE BIO, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
17
Largest Forms 3/4/5 holder
Donald Allen Williams
Net 12M change
-$152,239
Latest report
08 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Donald Allen Williams Director $2,753,264 +$17,756 +0.65% Mixed 10 Jun 2026
Binxian Wei Director $1,077,529 Mixed 10 Jun 2026
Emil Chuang Director $1,071,875 Mixed 10 Jun 2026
Yuma Regional Medical Center 10%+ Owner $925,331 Mixed 19 Aug 2021
Robert Baltera Jr. Director $903,484 +$250,182 +38% Filing P/S 08 Jul 2026
Jordan Michael Zwick Director $589,582 Mixed 10 Jun 2026
John David Finley CEO, CFO, Director $381,043 -$310,161 -45% Mixed 06 Jul 2026
Mitchell Lawrence Jones Chief Medical Officer $193,047 -$110,016 -36% Filing P/S 06 Jul 2026
Thomas Hallam Chief Executive Officer, Director $29,372 Mixed 16 Aug 2022
Michael John Dawson Chief Medical Officer $7,650 Mixed 29 Mar 2022
Cristina Csimma Director $5,609 Mixed 08 Feb 2024
Stephanie Diaz Director $5,582 Mixed 08 Feb 2024
James R. Neal Director $4,762 Mixed 09 Feb 2024
Robert J. Trenschel Director $4,762 Mixed 08 Feb 2024
Mary Ann Gray Director $2,968 Mixed 21 Nov 2023
Robert Curtis McRae Chief Operating Officer $1,320 Mixed 03 Apr 2023
Margery B. Fischbein Director Mixed 11 Jul 2024

Recent insider transactions for PALISADE BIO, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Robert Baltera Jr. PALI Common Stock Purchase 5.72% $48,900 $1.96 25,000 461,904 09 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Purchase 4.8% $39,798 $1.99 20,000 436,904 08 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Purchase 7.75% $61,044 $2.03 30,000 416,904 07 Jul 2026 Direct
Mitchell Lawrence Jones PALI Common Stock Sale -35.6% $106,536 $2.05 -51,880 94,009 07 Jul 2026 Direct
John David Finley PALI Common Stock Options Exercise 0.06% 133 217,688 07 Jul 2026 Direct
John David Finley PALI Common Stock Sale -40.3% $303,343 $2.07 -146,798 217,555 07 Jul 2026 Direct
John David Finley PALI Series 2 Common Stock Purchase Warrant Options Exercise -100% -133 0 07 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Purchase 5.45% $41,040 $2.05 20,000 386,904 06 Jul 2026 Direct
Mitchell Lawrence Jones PALI Common Stock Options Exercise 891% 131,167 145,889 06 Jul 2026 Direct
Mitchell Lawrence Jones PALI Restricted Stock Units Options Exercise -16.7% -131,167 655,833 06 Jul 2026 Direct
John David Finley PALI Common Stock Options Exercise 1148.4% 335,167 364,353 06 Jul 2026 Direct
John David Finley PALI Restricted Stock Units Options Exercise -16.7% -335,167 1,675,833 06 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Purchase 2.8% $19,800 $1.98 10,000 366,904 02 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Purchase 5.94% $39,600 $1.98 20,000 356,904 01 Jul 2026 Direct
Robert Baltera Jr. PALI Common Stock Award 336,904 336,904 10 Jun 2026 Direct
Binxian Wei PALI Common Stock Options Exercise 3.41% 20,200 613,355 10 Jun 2026 Direct
Binxian Wei PALI Common Stock Award 69274.8% 592,300 593,155 10 Jun 2026 Direct
Binxian Wei PALI Restricted Stock Units Options Exercise -33.3% -20,200 40,400 10 Jun 2026 Direct
Donald Allen Williams PALI Common Stock Options Exercise 4.02% 60,666 1,570,294 10 Jun 2026 Direct
Donald Allen Williams PALI Common Stock Award 13971.8% 1,498,900 1,509,628 10 Jun 2026 Direct
Donald Allen Williams PALI Restricted Stock Units Options Exercise -33.3% -60,666 121,334 10 Jun 2026 Direct
Emil Chuang PALI Common Stock Options Exercise 3.41% 20,200 612,500 10 Jun 2026 Direct
Emil Chuang PALI Common Stock Award 592,300 592,300 10 Jun 2026 Direct
Emil Chuang PALI Restricted Stock Units Options Exercise -33.3% -20,200 40,400 10 Jun 2026 Direct
Jordan Michael Zwick PALI Common Stock Award 336,904 336,904 10 Jun 2026 Direct
Mitchell Lawrence Jones PALI Common Stock Sale -13% $3,481 $1.75 -1,989 13,263 12 Feb 2026 Direct
John David Finley PALI Common Stock Sale -12.5% $6,818 $1.75 -3,896 27,353 12 Feb 2026 Direct
Mitchell Lawrence Jones PALI Common Stock Options Exercise 110.3% 8,000 15,252 11 Feb 2026 Direct
Mitchell Lawrence Jones PALI Restricted Stock Units Options Exercise -33.3% -8,000 16,000 11 Feb 2026 Direct
John David Finley PALI Common Stock Options Exercise 74.4% 13,333 31,249 11 Feb 2026 Direct
John David Finley PALI Restricted Stock Units Options Exercise -33.3% -13,333 26,667 11 Feb 2026 Direct
Mitchell Lawrence Jones PALI Restricted Stock Units Award 787,000 787,000 09 Feb 2026 Direct
John David Finley PALI Restricted Stock Units Award 2,011,000 2,011,000 09 Feb 2026 Direct
Donald Allen Williams PALI Common Stock Purchase 87.3% $8,356 $1.67 5,000 10,728 16 Jan 2026 Direct
Donald Allen Williams PALI Common Stock Purchase 686.8% $9,400 $1.88 5,000 5,728 09 Jan 2026 Direct
Donald Allen Williams PALI Restricted Stock Units Award 182,000 182,000 06 Oct 2025 Direct
Binxian Wei PALI Restricted Stock Units Award 60,600 60,600 06 Oct 2025 Direct
Emil Chuang PALI Restricted Stock Units Award 60,600 60,600 06 Oct 2025 Direct
Mitchell Lawrence Jones PALI Restricted Stock Units Award 7,665,800 7,665,800 06 Oct 2025 Direct
John David Finley PALI Restricted Stock Units Award 9,179,400 9,179,400 06 Oct 2025 Direct
Donald Allen Williams PALI Phantom Units Award 64,400 64,400 04 Sep 2025 Direct
John David Finley PALI Phantom Units Award 323,400 323,400 04 Sep 2025 Direct
Binxian Wei PALI Phantom Units Award 18,800 18,800 04 Sep 2025 Direct
Mitchell Lawrence Jones PALI Phantom Units Award 289,000 289,000 04 Sep 2025 Direct
Emil Chuang PALI Phantom Units Award 18,800 18,800 04 Sep 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .